Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-02

Clinical Trial Update: Safety of Herceptin/Trastuzumab in Metastatic Breast Cancer

View source ↗

Summary

A completed clinical trial update assessing the safety of trastuzumab (Herceptin) in patients with metastatic breast cancer. The document summarizes safety find…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer, Metastatic Breast Cancer | Status: COMPLETED